Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?
Publication Type:
Journal Article
Citation:
Palmer S, Sculpher M, Philips Z, Robinson M, Ginnelly L, Bakhai A, Abrams K, Cooper N, Packham C, Alfakih K, Hall A and Gray D. Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? Int J Cardiol. 2005;100(2):229-40.
